发明授权
- 专利标题： Pyrrolopyrrolidinone compounds
- 专利标题（中）： 吡咯并吡咯烷酮化合物
-
申请号： US13900061申请日： 2013-05-22
-
公开(公告)号： US09365576B2公开(公告)日： 2016-06-14
- 发明人: Simona Cotesta , Pascal Furet , Vito Guagnano , Philipp Holzer , Joerg Kallen , Robert Mah , Keiichi Masuya , Achim Schlapbach , Stefan Stutz , Andrea Vaupel
- 申请人： Simona Cotesta , Pascal Furet , Vito Guagnano , Philipp Holzer , Joerg Kallen , Robert Mah , Keiichi Masuya , Achim Schlapbach , Stefan Stutz , Andrea Vaupel
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 Qian Zhang
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/407 ; A61K31/44 ; A61K31/5377 ; A61K31/506 ; A61K31/41 ; A61K31/4439 ; A61K45/06
摘要：
The invention relates to compounds of formula (I): as described herein, pharmaceutical preparations comprising such compounds, uses and methods of use for such compounds in the treatment of a disorder or a disease mediated by the activity of MDM2 and/or MDM4, and combinations comprising such compounds.
公开/授权文献
- US20130317024A1 PYRROLOPYRROLIDINONE COMPOUNDS 公开/授权日：2013-11-28
信息查询
